Total pendapatan perusahaan REGENXBIO Inc (RGNX)

regenxbio.com - logo grafis emiten RGNX

The reliability of REGENXBIO Inc. is ensured by strict adherence to temperature controls during the transport of biomaterials. The company's aggregate sales dynamics on the GURU.Markets chart visualize this process, where 0.15 determines the latest valuation metric. High authority in the field of gene therapy, combined with the pristine condition of its own production facilities, guarantees sustainable business growth.

REGENXBIO Inc. (RGNX) - Pendapatan lan volume dodolan saka 04.07.2022 nganti 17.11.2026

Rincian metrik komprehensif lan analitis REGENXBIO Corp (RGNX)

- nilai pasar lan prakiraan target analis:
Analisis umum perusahaan:REGENXBIO Inc.
Sampel barang Regenxbio

Effective capital management requires separating real business value from market speculation. For REGENXBIO Inc. (RGNX), stability is ensured by passive royalties from the use of vectors in third-party drugs. The GURU.Markets toolkit captures actual daily cash inflows through the dynamics of the company's operating sales revenue, stripping the data of news noise. This registry measures the real inflow of liquidity, excluding subjective expectations. The stability of such indicators confirms the viability of the model prior to the launch of its own products.

Analisis perusahaan pesaing

Tempus AI, Inc. (TEM) - Pendapatan reged perusahaan|Dodolan perusahaan QGEN (Qiagen NV)|Pendapatan lan volume dodolan Ionis Pharmaceuticals, Inc. (IONS)|Pendapatan lan volume dodolan RGEN (Repligen Inc.)|Avidity Corp (RNA) - Total pendapatan perusahaan|CRSP - Pendapatan perusahaan|Pendapatan reged perusahaan genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Pendapatan perusahaan|Total pendapatan perusahaan Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Twist Bioscience Corp TWST|Pendapatan lan volume dodolan TXG|Pendapatan lan volume dodolan intelliatx.com (NTLA)|Stoke Therapeutics - Dodolan perusahaan|BioLife Solutions Inc (BLFS) - Total pendapatan perusahaan|wavelifesciences.com - Pendapatan lan volume dodolan|Maze Therapeutics Corp (MAZE) - Dodolan perusahaan|SION: Pendapatan lan volume dodolan|Volume dodolan perusahaan PRME|Pendapatan perusahaan Taysha Gene Therapies|Volume dodolan perusahaan QURE (uniQure)|Pendapatan perusahaan MeiraGTx (MGTX)|Pendapatan reged perusahaan Solid Corp|Pendapatan lan volume dodolan OCGN (ocugen.com)|PACB (Pacific Biosciences) - Pendapatan tahunan perusahaan|Benitec Biopharma Inc - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Pendapatan perusahaan|4D Molecular Therapeutics (FDMT) - Pendapatan lan volume dodolan|LXEO (Lexeo Therapeutics, Inc.) - Pendapatan lan volume dodolan|Total pendapatan perusahaan korrobio.com KRRO|Dodolan perusahaan EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Volume dodolan perusahaan|Pendapatan perusahaan ProQR Therapeutics N.V. PRQR|Pendapatan reged perusahaan Codexis, Inc. (CDXS)|SGMO - Pendapatan perusahaan|nautilus.bio - Total dodolan perusahaan|Metagenomi, Inc (MGX) - Pendapatan perusahaan|Volume dodolan perusahaan DTIL|Pendapatan perusahaan Generation Bio|Pendapatan lan volume dodolan Boundless Bio Inc|Pendapatan perusahaan Exicure Corp (XCUR)|Pendapatan reged perusahaan Imunon|Pendapatan lan volume dodolan PHIO (phiopharma.com)|Total volume dodolan perusahaan mustangbio.com|RNAZ - Pendapatan perusahaan|Total pendapatan perusahaan Bionano Genomics|APDN: Pendapatan lan volume dodolan|Volume dodolan perusahaan BLUE|Dodolan perusahaan IPA|OMGA: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan OMIC|Pendapatan reged perusahaan Regulus Therapeutics|Pendapatan perusahaan Syros SYRS|Pendapatan dodolan perusahaan TBIO|TCON: Dodolan perusahaan|Unity Biotechnology, Inc. (UBX) - Dodolan perusahaan